nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—CYP1A2—Betaxolol—glaucoma	0.0964	0.264	CbGbCtD
Leflunomide—CYP2C9—Diclofenamide—glaucoma	0.0765	0.209	CbGbCtD
Leflunomide—CYP2C9—Dorzolamide—glaucoma	0.0739	0.202	CbGbCtD
Leflunomide—CYP2C9—Methazolamide—glaucoma	0.0658	0.18	CbGbCtD
Leflunomide—CYP1A2—Clonidine—glaucoma	0.0528	0.145	CbGbCtD
Leflunomide—AHR—Circadian rythm related genes—ATOH7—glaucoma	0.00601	0.0527	CbGpPWpGaD
Leflunomide—DHODH—Nucleotide metabolism—TXN—glaucoma	0.00482	0.0423	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—COL11A1—glaucoma	0.00363	0.0318	CbGpPWpGaD
Leflunomide—DHODH—Treprostinil—Latanoprost—glaucoma	0.00322	0.295	CbGdCrCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00288	0.0253	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.00288	0.0253	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—OPN4—glaucoma	0.00239	0.021	CbGpPWpGaD
Leflunomide—PTK2B—Signaling events mediated by VEGFR1 and VEGFR2—NCK2—glaucoma	0.00213	0.0187	CbGpPWpGaD
Leflunomide—PTK2B—Pindolol—Levobunolol—glaucoma	0.00213	0.195	CbGdCrCtD
Leflunomide—PTK2B—Pindolol—Carteolol—glaucoma	0.00213	0.195	CbGdCrCtD
Leflunomide—PTK2B—Pindolol—Metipranolol—glaucoma	0.00203	0.186	CbGdCrCtD
Leflunomide—Niflumic Acid—PTGS2—glaucoma	0.0019	1	CrCbGaD
Leflunomide—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00187	0.0164	CbGpPWpGaD
Leflunomide—PTK2B—IL-7 Signaling Pathway—BCL2L1—glaucoma	0.00174	0.0153	CbGpPWpGaD
Leflunomide—PTK2B—IL-2 Signaling Pathway—CCND2—glaucoma	0.0016	0.014	CbGpPWpGaD
Leflunomide—PTK2B—IL-7 Signaling Pathway—BAD—glaucoma	0.00158	0.0138	CbGpPWpGaD
Leflunomide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.0015	0.0132	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—NCK2—glaucoma	0.00148	0.013	CbGpPWpGaD
Leflunomide—PTK2B—Pindolol—Betaxolol—glaucoma	0.00142	0.13	CbGdCrCtD
Leflunomide—PTK2B—Signaling by VEGF—NCK2—glaucoma	0.0014	0.0123	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CA5A—glaucoma	0.00139	0.0122	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NARFL—glaucoma	0.00139	0.0122	CbGpPWpGaD
Leflunomide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00137	0.012	CbGpPWpGaD
Leflunomide—PTK2B—Alpha-synuclein signaling—BAD—glaucoma	0.00133	0.0117	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.0013	0.0114	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—CAV2—glaucoma	0.00129	0.0113	CbGpPWpGaD
Leflunomide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00129	0.0113	CbGpPWpGaD
Leflunomide—PTK2B—Alpha4 beta1 integrin signaling events—FN1—glaucoma	0.00128	0.0112	CbGpPWpGaD
Leflunomide—PTK2B—Cell-Cell communication—NCK2—glaucoma	0.00127	0.0111	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.00123	0.0108	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.00123	0.0108	CbGpPWpGaD
Leflunomide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00117	0.0103	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NCK2—glaucoma	0.00117	0.0103	CbGpPWpGaD
Leflunomide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00114	0.01	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—MMP2—glaucoma	0.00114	0.01	CbGpPWpGaD
Leflunomide—PTK2B—IL-7 Signaling Pathway—CDKN1B—glaucoma	0.0011	0.00964	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—NCK2—glaucoma	0.00106	0.00934	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.00102	0.00897	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—EDN1—glaucoma	0.000994	0.00872	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—glaucoma	0.000929	0.00814	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—NR3C1—glaucoma	0.000928	0.00814	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—FAS—glaucoma	0.000899	0.00788	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000876	0.00768	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000876	0.00768	CbGpPWpGaD
Leflunomide—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000872	0.00764	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—MMP9—glaucoma	0.000857	0.00752	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—NGFR—glaucoma	0.000852	0.00747	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—MMP1—glaucoma	0.000836	0.00733	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—MMP1—glaucoma	0.000815	0.00715	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—NTRK1—glaucoma	0.00081	0.0071	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—FN1—glaucoma	0.000763	0.00669	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000757	0.00663	CbGpPWpGaD
Leflunomide—PTK2B—Signaling events mediated by VEGFR1 and VEGFR2—CAV1—glaucoma	0.000754	0.00661	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1A—glaucoma	0.000743	0.00652	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NTRK2—glaucoma	0.000712	0.00624	CbGpPWpGaD
Leflunomide—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000695	0.0061	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000682	0.00598	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CA1—glaucoma	0.00068	0.00596	CbGpPWpGaD
Leflunomide—ABCG2—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000677	0.00594	CbGpPWpGaD
Leflunomide—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000672	0.00589	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—FAS—glaucoma	0.000662	0.00581	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CTSA—glaucoma	0.000658	0.00577	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1A—glaucoma	0.000642	0.00563	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—MMP2—glaucoma	0.000639	0.0056	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—FAS—glaucoma	0.000634	0.00556	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CA2—glaucoma	0.000622	0.00545	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NGFR—glaucoma	0.000611	0.00536	CbGpPWpGaD
Leflunomide—PTK2B—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	0.000608	0.00533	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1B—glaucoma	0.000603	0.00528	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—BAD—glaucoma	0.000599	0.00525	CbGpPWpGaD
Leflunomide—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000594	0.00521	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NTRK1—glaucoma	0.00058	0.00509	CbGpPWpGaD
Leflunomide—PTK2B—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—glaucoma	0.00057	0.005	CbGpPWpGaD
Leflunomide—PTK2B—FGF signaling pathway—MMP9—glaucoma	0.00055	0.00482	CbGpPWpGaD
Leflunomide—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000537	0.00471	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—BDNF—glaucoma	0.000531	0.00466	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—CDKN1B—glaucoma	0.000525	0.0046	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—CAV1—glaucoma	0.000524	0.0046	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—CDKN1B—glaucoma	0.000512	0.00449	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—CAV1—glaucoma	0.000495	0.00434	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—MMP9—glaucoma	0.00048	0.00421	CbGpPWpGaD
Leflunomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000473	0.00415	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NGF—glaucoma	0.000472	0.00414	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000459	0.00402	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000445	0.0039	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—TXN—glaucoma	0.000438	0.00384	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—VEGFA—glaucoma	0.000436	0.00383	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—glaucoma	0.00043	0.00377	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—VEGFA—glaucoma	0.000426	0.00373	CbGpPWpGaD
Leflunomide—PTK2B—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—glaucoma	0.000411	0.0036	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000409	0.00358	CbGpPWpGaD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000404	0.00354	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—NOS3—glaucoma	0.000397	0.00348	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000395	0.00346	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—BAD—glaucoma	0.000389	0.00341	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—MMP9—glaucoma	0.000386	0.00339	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TNF—glaucoma	0.000382	0.00335	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—CAV1—glaucoma	0.000376	0.0033	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—NOS3—glaucoma	0.000374	0.00328	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000371	0.00325	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000347	0.00305	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GSTT1—glaucoma	0.00034	0.00298	CbGpPWpGaD
Leflunomide—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.000332	0.00291	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—TP53—glaucoma	0.000322	0.00282	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000317	0.00278	CbGpPWpGaD
Leflunomide—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000317	0.00278	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000317	0.00278	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LRP12—glaucoma	0.000307	0.00269	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000302	0.00265	CbGpPWpGaD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.0003	0.00263	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1A—glaucoma	0.0003	0.00263	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000299	0.00262	CbGpPWpGaD
Leflunomide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000298	0.00262	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000297	0.0026	CbGpPWpGaD
Leflunomide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000296	0.0026	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTSA—glaucoma	0.000296	0.0026	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—VEGFA—glaucoma	0.000286	0.0025	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—NOS3—glaucoma	0.000285	0.0025	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000276	0.00242	CbGpPWpGaD
Leflunomide—Weight decreased—Timolol—glaucoma	0.000273	0.000537	CcSEcCtD
Leflunomide—Constipation—Travoprost—glaucoma	0.000272	0.000536	CcSEcCtD
Leflunomide—Pain—Travoprost—glaucoma	0.000272	0.000536	CcSEcCtD
Leflunomide—Hyperglycaemia—Timolol—glaucoma	0.000272	0.000536	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000271	0.000534	CcSEcCtD
Leflunomide—Paraesthesia—Pilocarpine—glaucoma	0.000271	0.000534	CcSEcCtD
Leflunomide—Asthenia—Bimatoprost—glaucoma	0.000271	0.000534	CcSEcCtD
Leflunomide—Fatigue—Brinzolamide—glaucoma	0.000271	0.000533	CcSEcCtD
Leflunomide—DHODH—Metabolism—ABCA1—glaucoma	0.000271	0.00237	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CYP1B1—glaucoma	0.000271	0.00237	CbGpPWpGaD
Leflunomide—Angioedema—Clonidine—glaucoma	0.00027	0.000532	CcSEcCtD
Leflunomide—PTK2B—Signaling by VEGF—VEGFA—glaucoma	0.00027	0.00236	CbGpPWpGaD
Leflunomide—Dyspnoea—Pilocarpine—glaucoma	0.000269	0.00053	CcSEcCtD
Leflunomide—Pain—Brinzolamide—glaucoma	0.000269	0.000529	CcSEcCtD
Leflunomide—Pruritus—Bimatoprost—glaucoma	0.000267	0.000527	CcSEcCtD
Leflunomide—Immune system disorder—Betaxolol—glaucoma	0.000267	0.000526	CcSEcCtD
Leflunomide—Diarrhoea—Apraclonidine—glaucoma	0.000267	0.000525	CcSEcCtD
Leflunomide—Malaise—Clonidine—glaucoma	0.000266	0.000525	CcSEcCtD
Leflunomide—Mediastinal disorder—Betaxolol—glaucoma	0.000266	0.000524	CcSEcCtD
Leflunomide—Dyspepsia—Pilocarpine—glaucoma	0.000266	0.000523	CcSEcCtD
Leflunomide—Chills—Betaxolol—glaucoma	0.000265	0.000522	CcSEcCtD
Leflunomide—Arrhythmia—Betaxolol—glaucoma	0.000264	0.00052	CcSEcCtD
Leflunomide—Feeling abnormal—Dorzolamide—glaucoma	0.000263	0.000519	CcSEcCtD
Leflunomide—Decreased appetite—Pilocarpine—glaucoma	0.000262	0.000517	CcSEcCtD
Leflunomide—Feeling abnormal—Travoprost—glaucoma	0.000262	0.000516	CcSEcCtD
Leflunomide—Conjunctivitis—Timolol—glaucoma	0.000261	0.000515	CcSEcCtD
Leflunomide—Gastrointestinal pain—Dorzolamide—glaucoma	0.000261	0.000515	CcSEcCtD
Leflunomide—Alopecia—Betaxolol—glaucoma	0.000261	0.000514	CcSEcCtD
Leflunomide—Palpitations—Clonidine—glaucoma	0.000261	0.000514	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000261	0.000513	CcSEcCtD
Leflunomide—Gastrointestinal pain—Travoprost—glaucoma	0.00026	0.000512	CcSEcCtD
Leflunomide—Feeling abnormal—Brinzolamide—glaucoma	0.000259	0.00051	CcSEcCtD
Leflunomide—Mental disorder—Betaxolol—glaucoma	0.000259	0.00051	CcSEcCtD
Leflunomide—Pain—Pilocarpine—glaucoma	0.000258	0.000509	CcSEcCtD
Leflunomide—Constipation—Pilocarpine—glaucoma	0.000258	0.000509	CcSEcCtD
Leflunomide—Cough—Clonidine—glaucoma	0.000258	0.000508	CcSEcCtD
Leflunomide—Dizziness—Apraclonidine—glaucoma	0.000258	0.000508	CcSEcCtD
Leflunomide—Malnutrition—Betaxolol—glaucoma	0.000257	0.000507	CcSEcCtD
Leflunomide—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	0.000257	0.00225	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000257	0.00225	CbGpPWpGaD
Leflunomide—Urticaria—Dorzolamide—glaucoma	0.000254	0.0005	CcSEcCtD
Leflunomide—Epistaxis—Timolol—glaucoma	0.000254	0.000499	CcSEcCtD
Leflunomide—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000253	0.00222	CbGpPWpGaD
Leflunomide—Abdominal pain—Dorzolamide—glaucoma	0.000253	0.000497	CcSEcCtD
Leflunomide—Body temperature increased—Dorzolamide—glaucoma	0.000253	0.000497	CcSEcCtD
Leflunomide—Sinusitis—Timolol—glaucoma	0.000252	0.000497	CcSEcCtD
Leflunomide—Dysgeusia—Betaxolol—glaucoma	0.000252	0.000496	CcSEcCtD
Leflunomide—Arthralgia—Clonidine—glaucoma	0.000252	0.000495	CcSEcCtD
Leflunomide—Chest pain—Clonidine—glaucoma	0.000252	0.000495	CcSEcCtD
Leflunomide—Abdominal pain—Travoprost—glaucoma	0.000251	0.000495	CcSEcCtD
Leflunomide—Agranulocytosis—Timolol—glaucoma	0.000251	0.000494	CcSEcCtD
Leflunomide—Anxiety—Clonidine—glaucoma	0.000251	0.000494	CcSEcCtD
Leflunomide—Asthenia—Acetazolamide—glaucoma	0.00025	0.000493	CcSEcCtD
Leflunomide—Dizziness—Bimatoprost—glaucoma	0.00025	0.000492	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00025	0.000492	CcSEcCtD
Leflunomide—Urticaria—Brinzolamide—glaucoma	0.00025	0.000491	CcSEcCtD
Leflunomide—PTK2B—Immune System—TXNIP—glaucoma	0.000249	0.00219	CbGpPWpGaD
Leflunomide—Feeling abnormal—Pilocarpine—glaucoma	0.000249	0.00049	CcSEcCtD
Leflunomide—Discomfort—Clonidine—glaucoma	0.000248	0.000489	CcSEcCtD
Leflunomide—Vomiting—Apraclonidine—glaucoma	0.000248	0.000488	CcSEcCtD
Leflunomide—Muscle spasms—Betaxolol—glaucoma	0.000247	0.000487	CcSEcCtD
Leflunomide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000247	0.000486	CcSEcCtD
Leflunomide—Hypersensitivity—Brimonidine—glaucoma	0.000247	0.000485	CcSEcCtD
Leflunomide—Dry mouth—Clonidine—glaucoma	0.000246	0.000484	CcSEcCtD
Leflunomide—Dermatitis—Apraclonidine—glaucoma	0.000245	0.000484	CcSEcCtD
Leflunomide—PTK2B—Immune System—TBK1—glaucoma	0.000244	0.00214	CbGpPWpGaD
Leflunomide—Headache—Apraclonidine—glaucoma	0.000244	0.000481	CcSEcCtD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000243	0.00213	CbGpPWpGaD
Leflunomide—Vision blurred—Betaxolol—glaucoma	0.000242	0.000477	CcSEcCtD
Leflunomide—Rhinitis—Timolol—glaucoma	0.000242	0.000477	CcSEcCtD
Leflunomide—Asthenia—Brimonidine—glaucoma	0.00024	0.000473	CcSEcCtD
Leflunomide—Infection—Clonidine—glaucoma	0.00024	0.000472	CcSEcCtD
Leflunomide—Body temperature increased—Pilocarpine—glaucoma	0.000239	0.00047	CcSEcCtD
Leflunomide—Abdominal pain—Pilocarpine—glaucoma	0.000239	0.00047	CcSEcCtD
Leflunomide—Ill-defined disorder—Betaxolol—glaucoma	0.000239	0.00047	CcSEcCtD
Leflunomide—Diarrhoea—Acetazolamide—glaucoma	0.000239	0.00047	CcSEcCtD
Leflunomide—Rash—Bimatoprost—glaucoma	0.000238	0.000469	CcSEcCtD
Leflunomide—Dermatitis—Bimatoprost—glaucoma	0.000238	0.000469	CcSEcCtD
Leflunomide—Oedema peripheral—Timolol—glaucoma	0.000238	0.000468	CcSEcCtD
Leflunomide—Anaemia—Betaxolol—glaucoma	0.000238	0.000468	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—TP53—glaucoma	0.000237	0.00208	CbGpPWpGaD
Leflunomide—Connective tissue disorder—Timolol—glaucoma	0.000237	0.000467	CcSEcCtD
Leflunomide—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000237	0.00208	CbGpPWpGaD
Leflunomide—Pruritus—Brimonidine—glaucoma	0.000237	0.000466	CcSEcCtD
Leflunomide—Headache—Bimatoprost—glaucoma	0.000237	0.000466	CcSEcCtD
Leflunomide—Nervous system disorder—Clonidine—glaucoma	0.000236	0.000466	CcSEcCtD
Leflunomide—Thrombocytopenia—Clonidine—glaucoma	0.000236	0.000465	CcSEcCtD
Leflunomide—Hypersensitivity—Dorzolamide—glaucoma	0.000235	0.000464	CcSEcCtD
Leflunomide—Tachycardia—Clonidine—glaucoma	0.000235	0.000463	CcSEcCtD
Leflunomide—Hypersensitivity—Travoprost—glaucoma	0.000234	0.000462	CcSEcCtD
Leflunomide—Skin disorder—Clonidine—glaucoma	0.000234	0.000461	CcSEcCtD
Leflunomide—Hyperhidrosis—Clonidine—glaucoma	0.000233	0.000459	CcSEcCtD
Leflunomide—Malaise—Betaxolol—glaucoma	0.000232	0.000457	CcSEcCtD
Leflunomide—Nausea—Apraclonidine—glaucoma	0.000231	0.000456	CcSEcCtD
Leflunomide—Hypersensitivity—Brinzolamide—glaucoma	0.000231	0.000456	CcSEcCtD
Leflunomide—Vertigo—Betaxolol—glaucoma	0.000231	0.000455	CcSEcCtD
Leflunomide—Dizziness—Acetazolamide—glaucoma	0.000231	0.000454	CcSEcCtD
Leflunomide—Anorexia—Clonidine—glaucoma	0.00023	0.000453	CcSEcCtD
Leflunomide—Asthenia—Dorzolamide—glaucoma	0.000229	0.000452	CcSEcCtD
Leflunomide—Asthenia—Travoprost—glaucoma	0.000228	0.00045	CcSEcCtD
Leflunomide—Palpitations—Betaxolol—glaucoma	0.000227	0.000448	CcSEcCtD
Leflunomide—Pruritus—Dorzolamide—glaucoma	0.000226	0.000445	CcSEcCtD
Leflunomide—Eye disorder—Timolol—glaucoma	0.000226	0.000444	CcSEcCtD
Leflunomide—Asthenia—Brinzolamide—glaucoma	0.000225	0.000444	CcSEcCtD
Leflunomide—Hypotension—Clonidine—glaucoma	0.000225	0.000444	CcSEcCtD
Leflunomide—ABCG2—Metabolism—NARFL—glaucoma	0.000225	0.00197	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CA5A—glaucoma	0.000225	0.00197	CbGpPWpGaD
Leflunomide—Pruritus—Travoprost—glaucoma	0.000225	0.000443	CcSEcCtD
Leflunomide—Cough—Betaxolol—glaucoma	0.000224	0.000442	CcSEcCtD
Leflunomide—Nausea—Bimatoprost—glaucoma	0.000224	0.000442	CcSEcCtD
Leflunomide—Cardiac disorder—Timolol—glaucoma	0.000224	0.000441	CcSEcCtD
Leflunomide—Hypersensitivity—Pilocarpine—glaucoma	0.000222	0.000438	CcSEcCtD
Leflunomide—Pruritus—Brinzolamide—glaucoma	0.000222	0.000438	CcSEcCtD
Leflunomide—Vomiting—Acetazolamide—glaucoma	0.000222	0.000437	CcSEcCtD
Leflunomide—Dizziness—Brimonidine—glaucoma	0.000221	0.000436	CcSEcCtD
Leflunomide—PTK2B—Immune System—C1QB—glaucoma	0.000221	0.00194	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Clonidine—glaucoma	0.00022	0.000433	CcSEcCtD
Leflunomide—Chest pain—Betaxolol—glaucoma	0.000219	0.000431	CcSEcCtD
Leflunomide—Arthralgia—Betaxolol—glaucoma	0.000219	0.000431	CcSEcCtD
Leflunomide—Myalgia—Betaxolol—glaucoma	0.000219	0.000431	CcSEcCtD
Leflunomide—Diarrhoea—Dorzolamide—glaucoma	0.000219	0.000431	CcSEcCtD
Leflunomide—Headache—Acetazolamide—glaucoma	0.000218	0.00043	CcSEcCtD
Leflunomide—Anxiety—Betaxolol—glaucoma	0.000218	0.00043	CcSEcCtD
Leflunomide—Insomnia—Clonidine—glaucoma	0.000218	0.00043	CcSEcCtD
Leflunomide—Immune system disorder—Timolol—glaucoma	0.000218	0.000429	CcSEcCtD
Leflunomide—Diarrhoea—Travoprost—glaucoma	0.000218	0.000429	CcSEcCtD
Leflunomide—Mediastinal disorder—Timolol—glaucoma	0.000218	0.000428	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000217	0.000428	CcSEcCtD
Leflunomide—Asthenia—Pilocarpine—glaucoma	0.000217	0.000427	CcSEcCtD
Leflunomide—Paraesthesia—Clonidine—glaucoma	0.000217	0.000426	CcSEcCtD
Leflunomide—Discomfort—Betaxolol—glaucoma	0.000216	0.000426	CcSEcCtD
Leflunomide—DHODH—Metabolism—GSTM1—glaucoma	0.000216	0.0019	CbGpPWpGaD
Leflunomide—Arrhythmia—Timolol—glaucoma	0.000216	0.000425	CcSEcCtD
Leflunomide—Dyspnoea—Clonidine—glaucoma	0.000215	0.000423	CcSEcCtD
Leflunomide—Diarrhoea—Brinzolamide—glaucoma	0.000215	0.000423	CcSEcCtD
Leflunomide—Dry mouth—Betaxolol—glaucoma	0.000214	0.000422	CcSEcCtD
Leflunomide—Pruritus—Pilocarpine—glaucoma	0.000214	0.000421	CcSEcCtD
Leflunomide—Alopecia—Timolol—glaucoma	0.000213	0.00042	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—OPN4—glaucoma	0.000213	0.00186	CbGpPWpGaD
Leflunomide—Mental disorder—Timolol—glaucoma	0.000211	0.000416	CcSEcCtD
Leflunomide—Dizziness—Dorzolamide—glaucoma	0.000211	0.000416	CcSEcCtD
Leflunomide—Rash—Brimonidine—glaucoma	0.000211	0.000415	CcSEcCtD
Leflunomide—Dermatitis—Brimonidine—glaucoma	0.000211	0.000415	CcSEcCtD
Leflunomide—Dizziness—Travoprost—glaucoma	0.00021	0.000414	CcSEcCtD
Leflunomide—Malnutrition—Timolol—glaucoma	0.00021	0.000414	CcSEcCtD
Leflunomide—Headache—Brimonidine—glaucoma	0.00021	0.000413	CcSEcCtD
Leflunomide—Decreased appetite—Clonidine—glaucoma	0.00021	0.000413	CcSEcCtD
Leflunomide—Infection—Betaxolol—glaucoma	0.000209	0.000411	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Clonidine—glaucoma	0.000208	0.00041	CcSEcCtD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000208	0.00182	CbGpPWpGaD
Leflunomide—Fatigue—Clonidine—glaucoma	0.000208	0.000409	CcSEcCtD
Leflunomide—Dizziness—Brinzolamide—glaucoma	0.000208	0.000409	CcSEcCtD
Leflunomide—Nausea—Acetazolamide—glaucoma	0.000207	0.000408	CcSEcCtD
Leflunomide—Diarrhoea—Pilocarpine—glaucoma	0.000207	0.000407	CcSEcCtD
Leflunomide—Pain—Clonidine—glaucoma	0.000206	0.000406	CcSEcCtD
Leflunomide—Constipation—Clonidine—glaucoma	0.000206	0.000406	CcSEcCtD
Leflunomide—Nervous system disorder—Betaxolol—glaucoma	0.000206	0.000405	CcSEcCtD
Leflunomide—Dysgeusia—Timolol—glaucoma	0.000206	0.000405	CcSEcCtD
Leflunomide—Thrombocytopenia—Betaxolol—glaucoma	0.000206	0.000405	CcSEcCtD
Leflunomide—Tachycardia—Betaxolol—glaucoma	0.000205	0.000403	CcSEcCtD
Leflunomide—Skin disorder—Betaxolol—glaucoma	0.000204	0.000402	CcSEcCtD
Leflunomide—Vomiting—Dorzolamide—glaucoma	0.000203	0.0004	CcSEcCtD
Leflunomide—Hyperhidrosis—Betaxolol—glaucoma	0.000203	0.0004	CcSEcCtD
Leflunomide—Rash—Dorzolamide—glaucoma	0.000201	0.000397	CcSEcCtD
Leflunomide—Dermatitis—Dorzolamide—glaucoma	0.000201	0.000396	CcSEcCtD
Leflunomide—Rash—Travoprost—glaucoma	0.000201	0.000395	CcSEcCtD
Leflunomide—Dermatitis—Travoprost—glaucoma	0.0002	0.000395	CcSEcCtD
Leflunomide—Headache—Dorzolamide—glaucoma	0.0002	0.000394	CcSEcCtD
Leflunomide—Anorexia—Betaxolol—glaucoma	0.0002	0.000394	CcSEcCtD
Leflunomide—Vomiting—Brinzolamide—glaucoma	0.0002	0.000393	CcSEcCtD
Leflunomide—Dizziness—Pilocarpine—glaucoma	0.0002	0.000393	CcSEcCtD
Leflunomide—Headache—Travoprost—glaucoma	0.000199	0.000393	CcSEcCtD
Leflunomide—Nausea—Brimonidine—glaucoma	0.000199	0.000391	CcSEcCtD
Leflunomide—Feeling abnormal—Clonidine—glaucoma	0.000199	0.000391	CcSEcCtD
Leflunomide—Rash—Brinzolamide—glaucoma	0.000198	0.00039	CcSEcCtD
Leflunomide—Vision blurred—Timolol—glaucoma	0.000198	0.00039	CcSEcCtD
Leflunomide—Dermatitis—Brinzolamide—glaucoma	0.000198	0.00039	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—HEYL—glaucoma	0.000198	0.00173	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Clonidine—glaucoma	0.000197	0.000388	CcSEcCtD
Leflunomide—PTK2B—Immune System—TXN—glaucoma	0.000197	0.00173	CbGpPWpGaD
Leflunomide—Headache—Brinzolamide—glaucoma	0.000197	0.000388	CcSEcCtD
Leflunomide—Hypotension—Betaxolol—glaucoma	0.000196	0.000386	CcSEcCtD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000195	0.00171	CbGpPWpGaD
Leflunomide—Angioedema—Timolol—glaucoma	0.000192	0.000378	CcSEcCtD
Leflunomide—Vomiting—Pilocarpine—glaucoma	0.000192	0.000378	CcSEcCtD
Leflunomide—Urticaria—Clonidine—glaucoma	0.000192	0.000377	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—PTGFR—glaucoma	0.000191	0.00168	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000191	0.000377	CcSEcCtD
Leflunomide—DHODH—Metabolism—MTHFR—glaucoma	0.000191	0.00168	CbGpPWpGaD
Leflunomide—Body temperature increased—Clonidine—glaucoma	0.000191	0.000375	CcSEcCtD
Leflunomide—Abdominal pain—Clonidine—glaucoma	0.000191	0.000375	CcSEcCtD
Leflunomide—Rash—Pilocarpine—glaucoma	0.00019	0.000375	CcSEcCtD
Leflunomide—Dermatitis—Pilocarpine—glaucoma	0.00019	0.000375	CcSEcCtD
Leflunomide—Insomnia—Betaxolol—glaucoma	0.00019	0.000374	CcSEcCtD
Leflunomide—Nausea—Dorzolamide—glaucoma	0.00019	0.000374	CcSEcCtD
Leflunomide—Headache—Pilocarpine—glaucoma	0.000189	0.000373	CcSEcCtD
Leflunomide—Nausea—Travoprost—glaucoma	0.000189	0.000372	CcSEcCtD
Leflunomide—Vertigo—Timolol—glaucoma	0.000189	0.000372	CcSEcCtD
Leflunomide—Paraesthesia—Betaxolol—glaucoma	0.000188	0.000371	CcSEcCtD
Leflunomide—Dyspnoea—Betaxolol—glaucoma	0.000187	0.000369	CcSEcCtD
Leflunomide—Nausea—Brinzolamide—glaucoma	0.000187	0.000367	CcSEcCtD
Leflunomide—Palpitations—Timolol—glaucoma	0.000186	0.000366	CcSEcCtD
Leflunomide—Dyspepsia—Betaxolol—glaucoma	0.000185	0.000364	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000184	0.00161	CbGpPWpGaD
Leflunomide—Cough—Timolol—glaucoma	0.000183	0.000361	CcSEcCtD
Leflunomide—Decreased appetite—Betaxolol—glaucoma	0.000182	0.000359	CcSEcCtD
Leflunomide—Hypertension—Timolol—glaucoma	0.000181	0.000357	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000181	0.000357	CcSEcCtD
Leflunomide—Fatigue—Betaxolol—glaucoma	0.000181	0.000356	CcSEcCtD
Leflunomide—Pain—Betaxolol—glaucoma	0.00018	0.000354	CcSEcCtD
Leflunomide—Constipation—Betaxolol—glaucoma	0.00018	0.000354	CcSEcCtD
Leflunomide—Nausea—Pilocarpine—glaucoma	0.000179	0.000353	CcSEcCtD
Leflunomide—Chest pain—Timolol—glaucoma	0.000179	0.000352	CcSEcCtD
Leflunomide—Arthralgia—Timolol—glaucoma	0.000179	0.000352	CcSEcCtD
Leflunomide—Myalgia—Timolol—glaucoma	0.000179	0.000352	CcSEcCtD
Leflunomide—Anxiety—Timolol—glaucoma	0.000178	0.000351	CcSEcCtD
Leflunomide—DHODH—Metabolism—APOE—glaucoma	0.000178	0.00156	CbGpPWpGaD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000178	0.00035	CcSEcCtD
Leflunomide—Hypersensitivity—Clonidine—glaucoma	0.000178	0.00035	CcSEcCtD
Leflunomide—Discomfort—Timolol—glaucoma	0.000177	0.000348	CcSEcCtD
Leflunomide—DHODH—Metabolism—CAV1—glaucoma	0.000176	0.00155	CbGpPWpGaD
Leflunomide—Dry mouth—Timolol—glaucoma	0.000175	0.000345	CcSEcCtD
Leflunomide—Asthenia—Clonidine—glaucoma	0.000173	0.000341	CcSEcCtD
Leflunomide—Feeling abnormal—Betaxolol—glaucoma	0.000173	0.000341	CcSEcCtD
Leflunomide—Anaphylactic shock—Timolol—glaucoma	0.000171	0.000338	CcSEcCtD
Leflunomide—Pruritus—Clonidine—glaucoma	0.000171	0.000336	CcSEcCtD
Leflunomide—Infection—Timolol—glaucoma	0.00017	0.000336	CcSEcCtD
Leflunomide—Nervous system disorder—Timolol—glaucoma	0.000168	0.000331	CcSEcCtD
Leflunomide—Urticaria—Betaxolol—glaucoma	0.000167	0.000328	CcSEcCtD
Leflunomide—Skin disorder—Timolol—glaucoma	0.000167	0.000328	CcSEcCtD
Leflunomide—Body temperature increased—Betaxolol—glaucoma	0.000166	0.000327	CcSEcCtD
Leflunomide—Hyperhidrosis—Timolol—glaucoma	0.000166	0.000327	CcSEcCtD
Leflunomide—Diarrhoea—Clonidine—glaucoma	0.000165	0.000325	CcSEcCtD
Leflunomide—Anorexia—Timolol—glaucoma	0.000163	0.000322	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000162	0.00142	CbGpPWpGaD
Leflunomide—Hypotension—Timolol—glaucoma	0.00016	0.000316	CcSEcCtD
Leflunomide—Dizziness—Clonidine—glaucoma	0.000159	0.000314	CcSEcCtD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.000157	0.00137	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Timolol—glaucoma	0.000156	0.000308	CcSEcCtD
Leflunomide—Insomnia—Timolol—glaucoma	0.000155	0.000305	CcSEcCtD
Leflunomide—Hypersensitivity—Betaxolol—glaucoma	0.000155	0.000305	CcSEcCtD
Leflunomide—Paraesthesia—Timolol—glaucoma	0.000154	0.000303	CcSEcCtD
Leflunomide—Vomiting—Clonidine—glaucoma	0.000153	0.000302	CcSEcCtD
Leflunomide—Dyspnoea—Timolol—glaucoma	0.000153	0.000301	CcSEcCtD
Leflunomide—Rash—Clonidine—glaucoma	0.000152	0.000299	CcSEcCtD
Leflunomide—Dermatitis—Clonidine—glaucoma	0.000152	0.000299	CcSEcCtD
Leflunomide—Headache—Clonidine—glaucoma	0.000151	0.000297	CcSEcCtD
Leflunomide—Dyspepsia—Timolol—glaucoma	0.000151	0.000297	CcSEcCtD
Leflunomide—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000151	0.00132	CbGpPWpGaD
Leflunomide—Asthenia—Betaxolol—glaucoma	0.000151	0.000297	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—RPTOR—glaucoma	0.00015	0.00131	CbGpPWpGaD
Leflunomide—Decreased appetite—Timolol—glaucoma	0.000149	0.000294	CcSEcCtD
Leflunomide—Pruritus—Betaxolol—glaucoma	0.000149	0.000292	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Timolol—glaucoma	0.000148	0.000292	CcSEcCtD
Leflunomide—Fatigue—Timolol—glaucoma	0.000148	0.000291	CcSEcCtD
Leflunomide—Pain—Timolol—glaucoma	0.000147	0.000289	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—NCK2—glaucoma	0.000145	0.00127	CbGpPWpGaD
Leflunomide—Diarrhoea—Betaxolol—glaucoma	0.000144	0.000283	CcSEcCtD
Leflunomide—Nausea—Clonidine—glaucoma	0.000143	0.000282	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000143	0.00125	CbGpPWpGaD
Leflunomide—Feeling abnormal—Timolol—glaucoma	0.000141	0.000278	CcSEcCtD
Leflunomide—Gastrointestinal pain—Timolol—glaucoma	0.00014	0.000276	CcSEcCtD
Leflunomide—Dizziness—Betaxolol—glaucoma	0.000139	0.000273	CcSEcCtD
Leflunomide—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000139	0.00122	CbGpPWpGaD
Leflunomide—Urticaria—Timolol—glaucoma	0.000136	0.000268	CcSEcCtD
Leflunomide—Abdominal pain—Timolol—glaucoma	0.000136	0.000267	CcSEcCtD
Leflunomide—Body temperature increased—Timolol—glaucoma	0.000136	0.000267	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000135	0.00119	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000135	0.00119	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000135	0.00118	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000134	0.00117	CbGpPWpGaD
Leflunomide—Vomiting—Betaxolol—glaucoma	0.000133	0.000263	CcSEcCtD
Leflunomide—DHODH—Metabolism—NOS3—glaucoma	0.000133	0.00117	CbGpPWpGaD
Leflunomide—Rash—Betaxolol—glaucoma	0.000132	0.000261	CcSEcCtD
Leflunomide—Dermatitis—Betaxolol—glaucoma	0.000132	0.00026	CcSEcCtD
Leflunomide—Headache—Betaxolol—glaucoma	0.000132	0.000259	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	0.000129	0.00113	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	0.000127	0.00112	CbGpPWpGaD
Leflunomide—Hypersensitivity—Timolol—glaucoma	0.000126	0.000249	CcSEcCtD
Leflunomide—Nausea—Betaxolol—glaucoma	0.000125	0.000246	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—HDAC9—glaucoma	0.000123	0.00108	CbGpPWpGaD
Leflunomide—Asthenia—Timolol—glaucoma	0.000123	0.000242	CcSEcCtD
Leflunomide—DHODH—Metabolism—PTGS2—glaucoma	0.000122	0.00107	CbGpPWpGaD
Leflunomide—Pruritus—Timolol—glaucoma	0.000121	0.000239	CcSEcCtD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000121	0.00106	CbGpPWpGaD
Leflunomide—Diarrhoea—Timolol—glaucoma	0.000117	0.000231	CcSEcCtD
Leflunomide—CYP2C9—Metabolism—NARFL—glaucoma	0.000114	0.000997	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CA5A—glaucoma	0.000114	0.000997	CbGpPWpGaD
Leflunomide—Dizziness—Timolol—glaucoma	0.000113	0.000223	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000113	0.000988	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.00011	0.000968	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CA1—glaucoma	0.00011	0.000964	CbGpPWpGaD
Leflunomide—Vomiting—Timolol—glaucoma	0.000109	0.000215	CcSEcCtD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000109	0.000955	CbGpPWpGaD
Leflunomide—Rash—Timolol—glaucoma	0.000108	0.000213	CcSEcCtD
Leflunomide—Dermatitis—Timolol—glaucoma	0.000108	0.000213	CcSEcCtD
Leflunomide—Headache—Timolol—glaucoma	0.000107	0.000212	CcSEcCtD
Leflunomide—ABCG2—Metabolism—CTSA—glaucoma	0.000106	0.000934	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GSTM1—glaucoma	0.000103	0.000906	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000103	0.000905	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	0.000102	0.000894	CbGpPWpGaD
Leflunomide—Nausea—Timolol—glaucoma	0.000102	0.000201	CcSEcCtD
Leflunomide—ABCG2—Metabolism—CA2—glaucoma	0.000101	0.000882	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1A—glaucoma	9.79e-05	0.000858	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NARFL—glaucoma	9.72e-05	0.000852	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CA5A—glaucoma	9.72e-05	0.000852	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SMO—glaucoma	9.66e-05	0.000847	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	9.65e-05	0.000846	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	9.65e-05	0.000846	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NTRK2—glaucoma	8.83e-05	0.000774	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTM1—glaucoma	8.83e-05	0.000774	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	8.71e-05	0.000764	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—C3—glaucoma	8.6e-05	0.000754	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—BCL2L1—glaucoma	8.23e-05	0.000722	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NGFR—glaucoma	7.58e-05	0.000664	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—BAD—glaucoma	7.46e-05	0.000654	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NTRK1—glaucoma	7.2e-05	0.000631	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TXN—glaucoma	7.08e-05	0.000621	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CDKN2B—glaucoma	6.63e-05	0.000582	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—EDN1—glaucoma	6.37e-05	0.000558	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NGF—glaucoma	5.85e-05	0.000513	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—C3—glaucoma	5.56e-05	0.000488	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CA1—glaucoma	5.55e-05	0.000487	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTT1—glaucoma	5.49e-05	0.000482	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CTSA—glaucoma	5.38e-05	0.000471	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CDKN1B—glaucoma	5.2e-05	0.000456	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOE—glaucoma	5.18e-05	0.000454	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CAV1—glaucoma	5.13e-05	0.00045	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CA2—glaucoma	5.08e-05	0.000445	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.96e-05	0.000435	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.96e-05	0.000435	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FN1—glaucoma	4.88e-05	0.000428	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—BAD—glaucoma	4.82e-05	0.000423	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CA1—glaucoma	4.74e-05	0.000416	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CTSA—glaucoma	4.6e-05	0.000403	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP1B1—glaucoma	4.38e-05	0.000384	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ABCA1—glaucoma	4.38e-05	0.000384	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CA2—glaucoma	4.34e-05	0.00038	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.24e-05	0.000372	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.24e-05	0.000372	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—glaucoma	3.88e-05	0.00034	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TXN—glaucoma	3.58e-05	0.000314	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTM1—glaucoma	3.5e-05	0.000307	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CDKN1B—glaucoma	3.36e-05	0.000295	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.26e-05	0.000286	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.23e-05	0.000284	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—glaucoma	3.11e-05	0.000273	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—glaucoma	3.09e-05	0.000271	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TXN—glaucoma	3.06e-05	0.000268	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOE—glaucoma	2.88e-05	0.000252	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAV1—glaucoma	2.85e-05	0.00025	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VEGFA—glaucoma	2.79e-05	0.000245	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.79e-05	0.000245	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTT1—glaucoma	2.77e-05	0.000243	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.76e-05	0.000242	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTT1—glaucoma	2.37e-05	0.000208	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.24e-05	0.000196	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCA1—glaucoma	2.21e-05	0.000194	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP1B1—glaucoma	2.21e-05	0.000194	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—glaucoma	2.16e-05	0.000189	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TP53—glaucoma	2.11e-05	0.000185	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—glaucoma	1.97e-05	0.000173	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.91e-05	0.000168	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP1B1—glaucoma	1.89e-05	0.000166	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCA1—glaucoma	1.89e-05	0.000166	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTM1—glaucoma	1.77e-05	0.000155	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—glaucoma	1.56e-05	0.000137	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTM1—glaucoma	1.51e-05	0.000132	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOE—glaucoma	1.45e-05	0.000127	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAV1—glaucoma	1.44e-05	0.000126	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—glaucoma	1.33e-05	0.000117	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOE—glaucoma	1.24e-05	0.000109	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAV1—glaucoma	1.23e-05	0.000108	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—glaucoma	1.09e-05	9.55e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—glaucoma	9.96e-06	8.74e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—glaucoma	9.31e-06	8.16e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—glaucoma	8.51e-06	7.46e-05	CbGpPWpGaD
